First Manhattan’s Gossamer Bio GOSS Stock Holding History

First Manhattan’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-60	Closed	–	–	1500
2020 Q4	$0	Hold	60	–	–	﹤0.01%	1360
2020 Q3	$0	Hold	60	–	–	﹤0.01%	1372
2020 Q2	$0	Hold	60	–	–	﹤0.01%	1408
2020 Q1	$0	Buy	+60	New	+$783	﹤0.01%	1399

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

First Manhattan's GOSS Position: Q1 2021 in Review

First Manhattan sold out of Gossamer Bio (GOSS) in Q1 2021, closing a stake of 60 shares.

First Manhattan first reported a position in GOSS in Q1 2020 and held it in 4 quarters. The position peaked at $0 in Q4 2020. 123 funds tracked by Wall St. Rank hold GOSS as of Q1 2021.

First Manhattan reported no remaining Gossamer Bio position as of Q1 2021 after selling out during the quarter.
First Manhattan sold 60 Gossamer Bio shares in Q1 2021.
First Manhattan first reported a position in Gossamer Bio in Q1 2020 and held it in 4 quarters.
First Manhattan's Gossamer Bio position peaked at $0 in Q4 2020.
123 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2021.

Based on First Manhattan's 13F filing for Q1 2021, filed 14 May 2021.